Source: PR Newswire

Press Release: Lilly Oncology : Lilly Oncology Showcases Innovation in Cancer Research at ASCO 2020

/PRNewswire/ -- Data from 23 studies across Eli Lilly and Company's (NYSE: LLY) oncology product portfolio will be presented at the 56th Annual Meeting of the...

Read full article »
Lilly Oncology's Competitors | Lilly Oncology's News | Lilly Oncology's Financials
Stay up-to-date with the latest news on Lilly Oncology
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Jake Van Naarden's photo - President & CEO of Lilly Oncology

President & CEO

Jake Van Naarden

CEO Approval Rating

- -/100

Read more
Stay up-to-date with the latest news on Lilly Oncology